Source date: 2026-06-09
Close Interested in this topic?
Receive an email as soon as an article is published by the editorial team on: Social, health (aid and benefits, disabled persons, caregivers and mediators, patients, medications, etc.)
Close This topic has been added to your alerts
You will receive an email as soon as an article is published by the editorial team on: Social, health (aid and benefits, disabled persons, caregivers and mediators, patients, medications, etc.).
You can unsubscribe at any time via my account > my alerts.
Starting June 16, 2026
Cadmium: A reimbursed screening test for overexposed individuals Published on June 10, 2026 - Service Public / Directorate of Legal and Administrative Information (Prime Minister's Office)
Individuals living in identified risk areas, or showing signs of poisoning, will be able to benefit from cadmium exposure screening at private laboratories starting June 16. Service Public informs you.
Starting June 16, 2026, cadmium exposure screening will be reimbursed by Health Insurance. This measure follows a decision by the National Union of Health Insurance Funds published in the Official Journal on June 2, 2026.
In 2024, the Haute Autorité de santé (HAS) recommended screening individuals "potentially overexposed to cadmium due to their place of residence." A report published by Anses in March 2026 proposed action levers to reduce the French population's body burden of this substance.
Cadmium exposure screening: who and how?
Cadmium exposure screening will be reimbursed by Health Insurance up to 60% for at-risk patients, performed at private laboratories (the remainder covered by supplementary health insurance). Patients will need to pay a flat-rate contribution of €2, as with every medical biology procedure or medical consultation.
This screening must be prescribed by a doctor and is intended for:
-
"individuals potentially overexposed to cadmium due to their place of residence," when the soil has been previously recognized by competent authorities as being polluted by cadmium;
-
individuals monitored due to "chronic poisoning" from cadmium linked to their place of residence.
The test consists of a urinary cadmium measurement (called cadmiuria) performed as the first step. A blood measurement (cadmiaemia), also reimbursed, may be carried out additionally if the cadmiuria level is high.
These measurements must be performed under conditions defined by the HAS.
A bill aimed at reducing health risks related to cadmium contamination in food was adopted by the National Assembly in its first reading on June 3, 2026. It provides for lowering the limit values for cadmium in phosphate fertilizers in France in two progressive stages. An implementing decree is planned.
Laws and references
See also
-
Cadmium File - ameli National Health Insurance Fund (Cnam)
-
Screening, management, and follow-up of individuals potentially overexposed to cadmium due to their place of residence Haute Autorité de santé
Agenda
-
Starting June 16, 2026 Public Health Cadmium: A reimbursed screening test for overexposed individuals Published on June 10, 2026
-
From June 1, 2026, to Jan. 15, 2027 Higher Education How to benefit from Parcoursup mobility aid? Published on May 12, 2026
-
From June 24 to July 21, 2026 Sales What are the dates for the summer 2026 sales? Published on May 7, 2026
-
Starting June 20, 2025 Sustainable Consumption Extended energy label applied to smartphones and tablets from June 20 Published on June 12, 2025
Source: Service-Public particuliers